Unlocking the Future of Longevity

The future of medicine isn’t treating disease - it’s preventing it.

Human longevity delivers unprecedented opportunity - from fixing national demographies, to giving individuals choice in their life trajectories.

Humankind is on the brink of an exponential future: from space travel to the singularity; now is the time to ensure that our biology doesn’t slow us down.

We are DeSci DAO, a new category of decentralized entity that brings together professional organizations to invest in both decentralized and traditional science/technology.

Our first market is ‘longevity’, a field that is demonstrating unprecedented promise and potential.

Mission

Fund and accelerate biotech and non-biotech companies toward market-ready products that realize the potential of human longvity.

From making aging diseases a thing of the past to preparing humankind for an exponential, AI-enabled future.

Commercial model: Deal universe

DeSci DAO Longevity's target investment categories:

Biotechnology & Genetic Engineering will directly impact human healthspan and longevity;

Brain Computer Interfaces are seen as a stepping stone towards merging human and machine intelligence;

Nanotechnology is poised to play a crucial role in life extension and moving towards singularity;

Robotics and Cybernetics will merge robotic and biological systems to enhance human capabilities;

Regenerative Medicine combines cutting-edge technologies and biological approaches to repair, replace, or regenerate damaged tissues and organs;

Market Size

The Industry is Booming

2024 was a year of renewed momentum for the longevity sector, with total financing reaching $8.49bn USD up from $3.82bn USD in 2023 (Longevity.Technology).

Projected Growth

The global anti-aging/longevity market is set to grow from $76.36 billion in 2024 to $366.58 billion by 2032 (Polaris Market Research).

Aging is the Next Frontier

DeSci DAO: Longevity is bridging the gap between biotech innovation and investment, creating life-extending solutions for future generations.

Leadership

Phil Newman

Co-Founder

Founder of Longevity. Technology, a leading longevity media and consumer brand.
20+ years in market-entry & commercialization, driving multi-million revenue programs.

Gourish Singla